MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
CCQ (Clinical COPD Questionnaire)


Developed by:
Thys van der Molen (The Netherlands)

Objective:
To measure clinical control in patients with COPD

Copyright:
© 2003 van der Molen et al. All rights reserved.

Reference publication:
Van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes, 2003 Apr 28;1(1):13


Conditions of use:

Academic and Clinical License:

The CCQ is free for academic and clinical use and can be obtained on the CCQ website.

Industry and Commercial License:

The use of the CCQ for industry sponsored research and other commercial uses is licensed by MAPI Research Trust on behalf of the Author.

It is subject to the following specific conditions :

User Agreement:

User is required to complete and sign a User Agreement in which specific conditions required by the Author are detailed.

Access fees:

carre6 Author's royalty fees:

- In academic research and individual clinical practice: free of charge

- For industry sponsored research and other commercial uses: 500 €* per protocol/application and per language-version requested.

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees:

For industry sponsored research and other commercial uses: 600 €* per study + an additional 250 €* per language-version requested.

These fees are payable to Mapi Research Trust.

* excluding VAT


Conditions to translate:

The CCQ has already been translated into various languages.
Please visit the CCQ website for the list of available translations or contact MAPI Research Trust.


Performing new translations:

Commercial and/or international studies:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by MAPI Institute.

Academic translations / Not funded Research and Evaluation studies:

CCQ translation guidelines will be provided to allow academics and clinicians to use the CCQ in their institution.


Review copy:

UK English version available in both time references (7 days & 24 hours) for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on the CCQ on the CCQ website and on PROQOLID

[ BACK ]

 

To access our catalog, please click here.

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
MAPI SAS / Registrat MAPI (France)

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index questionnaire
The Maryland State Medical Society - MedChi (USA)

ESS (Epworth Sleepiness Scale) 
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK) & Claudia Trenkwalder (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)